Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.40 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.40 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | ACLY | P53396 | 1/20 | 0.39 |
| ▸ | KDR | P35968 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | KCNQ3 | O43525 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL711773 | 0.90 | HDAC6 (0.42) | ALDH1A1HDAC1HDAC8HDAC6TSHR | |
| SCHEMBL712003 | 0.89 | HPGD (0.47) | ALDH1A1HPGDCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL711275 | 0.88 | HDAC6 (0.41) | ALDH1A1HPGDSMN1; SMN2HDAC1HDAC8 | |
| SCHEMBL711999 | 0.84 | HDAC1 (0.46) | ALDH1A1HPGDCYP1A2SMN1; SMN2HDAC1 | |
| SCHEMBL709376 | 0.81 | SCN9A (0.43) | ALDH1A1HPGDCYP2C19SMN1; SMN2LMNA | |
| SCHEMBL12011295 | 0.78 | HDAC6 (0.39) | ALDH1A1HDAC1HDAC8HDAC6TSHR | |
| SCHEMBL714409 | 0.76 | HDAC6 (0.43) | SMN1; SMN2HDAC1HDAC8HDAC6ACLY | |
| SCHEMBL8697590 | 0.74 | SMN1; SMN2 (0.48) | ALDH1A1HPGDCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL27871304 | 0.72 | ALDH1A1 (0.49) | ALDH1A1HPGDSMN1; SMN2HDAC1HDAC8 | |
| SCHEMBL8697588 | 0.72 | CYP1A2 (0.45) | ALDH1A1HPGDCYP1A2CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8252925-B2 | Method for the production of 3-phenyl(thio)uracils and dithiouracils | BASF AKTIENGESELLSCHAFT (DE) | 2012-08-28 | — | — | US | disclosed |
| US-8124818-B2 | Method for the production of 3-phenyl(thio) uracils and dithiouracils | BASF AKTIENGESELLSCHAFT (DE) | 2012-02-28 | — | — | US | disclosed |
| US-8124818-B2 | Method for the production of 3-phenyl(thio) uracils and dithiouracils | BASF AKTIENGESELLSCHAFT (DE) | 2012-02-28 | — | — | US | disclosed |
| US-20110152522-A1 | METHOD FOR THE PRODUCTION OF 3-PHENYL(THIO) URACILS AND DITHIOURACILS | BASF AKTIENGESSELSCHAFT (DE) | 2011-06-23 | — | — | US | disclosed |
| US-20110152522-A1 | METHOD FOR THE PRODUCTION OF 3-PHENYL(THIO) URACILS AND DITHIOURACILS | BASF AKTIENGESSELSCHAFT (DE) | 2011-06-23 | — | — | US | disclosed |
| US-20080033174-A1 | Method for the Production of 3-Phenyl (Thio) Uracils and Dithiouracils | BASF AKTIENGESELLSCHAFT (DE) | 2008-02-07 | — | — | US | disclosed |
| US-20080033174-A1 | Method for the Production of 3-Phenyl (Thio) Uracils and Dithiouracils | BASF AKTIENGESELLSCHAFT (DE) | 2008-02-07 | — | — | US | disclosed |
| EP-1773787-A1 | METHOD FOR THE PRODUCTION OF 3-PHENYL(THIO)URACILS AND DITHIOURACILS | BASF AKTIENGESELLSCHAFT (DE) | 2007-04-18 | — | — | EP | disclosed |
| WO-2006010474-A1 | METHOD FOR THE PRODUCTION OF 3-PHENYL(THIO)URACILS AND DITHIOURACILS | BASF AKTIENGESELLSCHAFT (DE) | 2006-02-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080033174-A1 | Method for the Production of 3-Phenyl (Thio) Uracils and Dithiouracils | TPMT, TYMP, TYMS | ALDH1A1 233/4885HPGD 505/4885CYP1A2 857/4885 |
| US-20110152522-A1 | METHOD FOR THE PRODUCTION OF 3-PHENYL(THIO) URACILS AND DITHIOURACILS | TPMT, TYMP, TYMS | ALDH1A1 233/4885HPGD 505/4885CYP1A2 857/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.